A Study of TEPEZZA® Treatment in Participants With Thyroid Eye Disease

Clinical trial NCT06389578 · COMPLETED

Trial details

NCT number: NCT06389578
Sponsor: Amgen
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Thyroid Eye Disease

Start date: 2022-07-14
Primary completion: 2023-02-28
Enrollment: 16

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.